Read our “Need to Know” summary and watch “Leading the Way: Equity, Accessibility and Diversity in Pancreatic Cancer Research” in its entirety on our YouTube channel.

Lustgarten and the Salk Institute announced a new strategic partnership supported by a $5 million grant and focused on identifying and validating potential targets for new pancreatic cancer drugs.

Solving the unique complexities of pancreatic cancer requires complex thinking and diversity of thought, education,training, background and experience.   We are committed to prioritizing and promoting diversity and inclusion acrossthe organization, including staff, volunteer leadership and research portfolio.  ResearchA rich field of experience and perspectives working on the complex problems associated with pancreatic cancer increases the […]

President Joe Biden may have a lot of tough work on his plate at home and around the work, but deserves credit this year for trying to take on cancer through a revived version of an initiative he led while vice president in the Obama administration – the Cancer Moonshot, the incoming CEO of the […]

Cancer relies on many tricks to survive and grow. One tactic is to manipulate cells in the noncancerous tissues and cells surrounding a tumor to help the cancer cells spread. Researchers have learned that cancer seems to have a particular fondness for nerves, traveling along them as if they were highways.

According to a new study, substances that are said to boost athletic performance can also activate a receptor that speeds up the development of pancreatic cancer in mice.